The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice
Within the last decade the role of the endocannabinoid system (ECS) has been a significant part of ophthalmic research, including both ocular physiology and the development of eye pathologies. It is known that this widespread cell-signaling system is involved in retinal neurobiological processes, in...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1500179/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832539897945128960 |
|---|---|
| author | Tomasz Charytoniuk Stanisław Półjanowski Mateusz Michalak Karolina Kaźmierczak Bartłomiej Kałużny |
| author_facet | Tomasz Charytoniuk Stanisław Półjanowski Mateusz Michalak Karolina Kaźmierczak Bartłomiej Kałużny |
| author_sort | Tomasz Charytoniuk |
| collection | DOAJ |
| description | Within the last decade the role of the endocannabinoid system (ECS) has been a significant part of ophthalmic research, including both ocular physiology and the development of eye pathologies. It is known that this widespread cell-signaling system is involved in retinal neurobiological processes, including visual signal processing, as well as neurotransmission. Furthermore, various research indicated the involvement of ECS in the molecular basis of various pathologies, mostly glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). Therefore, the researchers believe that this biological system, its receptors, pathways, and ligands might be considered as an auxiliary compound to reduce the number of patients suffering from ophthalmic diseases. Despite presented in the literature effects of the endocannabinoid system in the eye, none of the current ECS reviews presented a comprehensive description of the endocannabinoid system, its compounds, and, subsequently ophthalmic disorders. Thus, the aim of this review was to summarize all the major data, including the most up-to-date research, concerning a correlation between the endocannabinoid system and the major ophthalmic pathologies. |
| format | Article |
| id | doaj-art-5e4c7906cc3b4c418671f8e094d64f27 |
| institution | Kabale University |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-5e4c7906cc3b4c418671f8e094d64f272025-02-05T07:32:11ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-02-011210.3389/fmed.2025.15001791500179The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practiceTomasz CharytoniukStanisław PółjanowskiMateusz MichalakKarolina KaźmierczakBartłomiej KałużnyWithin the last decade the role of the endocannabinoid system (ECS) has been a significant part of ophthalmic research, including both ocular physiology and the development of eye pathologies. It is known that this widespread cell-signaling system is involved in retinal neurobiological processes, including visual signal processing, as well as neurotransmission. Furthermore, various research indicated the involvement of ECS in the molecular basis of various pathologies, mostly glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). Therefore, the researchers believe that this biological system, its receptors, pathways, and ligands might be considered as an auxiliary compound to reduce the number of patients suffering from ophthalmic diseases. Despite presented in the literature effects of the endocannabinoid system in the eye, none of the current ECS reviews presented a comprehensive description of the endocannabinoid system, its compounds, and, subsequently ophthalmic disorders. Thus, the aim of this review was to summarize all the major data, including the most up-to-date research, concerning a correlation between the endocannabinoid system and the major ophthalmic pathologies.https://www.frontiersin.org/articles/10.3389/fmed.2025.1500179/fullECSendocannabinoid systemretinaglaucomadiabetic retinopathyCB receptor |
| spellingShingle | Tomasz Charytoniuk Stanisław Półjanowski Mateusz Michalak Karolina Kaźmierczak Bartłomiej Kałużny The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice Frontiers in Medicine ECS endocannabinoid system retina glaucoma diabetic retinopathy CB receptor |
| title | The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice |
| title_full | The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice |
| title_fullStr | The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice |
| title_full_unstemmed | The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice |
| title_short | The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice |
| title_sort | endocannabinoid system and ophthalmic pathologies a review of molecular mechanisms and its implications for clinical practice |
| topic | ECS endocannabinoid system retina glaucoma diabetic retinopathy CB receptor |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1500179/full |
| work_keys_str_mv | AT tomaszcharytoniuk theendocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT stanisławpołjanowski theendocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT mateuszmichalak theendocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT karolinakazmierczak theendocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT bartłomiejkałuzny theendocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT tomaszcharytoniuk endocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT stanisławpołjanowski endocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT mateuszmichalak endocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT karolinakazmierczak endocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice AT bartłomiejkałuzny endocannabinoidsystemandophthalmicpathologiesareviewofmolecularmechanismsanditsimplicationsforclinicalpractice |